XIST
HEKTS
Market cap560mUSD
Nov 12, Last price
3.28TRY
Name
Hektas Ticaret TAS
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hektas Ticaret T.A.S., founded in 1956 and headquartered in Gebze, Turkey, is a leading Turkish company that manufactures, imports, and distributes a wide spectrum of agricultural and veterinary products. For the agricultural sector, their offerings include an extensive range of crop protection solutions such as fungicides, herbicides, insecticides, acaricides, biological insecticides, fumigants, nematicides, soil fumigants, and plant growth regulators. They also provide specialized winter care treatments, summer oils, and spreading agents. Furthermore, Hektas supplies various fertilizers, including foliar applications, organo-mineral compounds, and drip irrigation products, alongside other farming essentials and even tomato seeds. In the animal health domain, the company offers a diverse portfolio of veterinary pharmaceuticals, encompassing antibacterials, vitamin and mineral supplements, feed additives, anti-inflammatory drugs, and anti-parasitics. Their product line additionally features poultry health remedies, pet care items, and pet food.
Related entities
Parent
ORDU YARDIMLAŞMA KURUMU
Key people
Eren Dik
Non-Executive Chairman of the Board · since 2023
Can Oerueng
Non-Executive Vice Chairman of the Board · since 2023
Murat Kilic
Finance Director · since 2024
Enis Terzi
Chief Executive Officer, General Manager · since 2024
Cuneyt Koseoglu
Sales Director · since 2024
Tendu Arsan
Human Resources Director · since 2023
Mehmet Derin
Research and Development and Plant Nutrition Director · since 2021
Ayhan Goekbag
Technical Affairs Director · since 2024
Emrah Oezdemir
Supply Chain Director · since 2023
Ferhat Baglarlioglu
Non-Executive Director · since 2024
Gozde Erkoc
Non-Executive Director · since 2024
Sansel Yilmaz
Non-Executive Director · since 2023
Kadri Oezguenes
Non-Executive Independent Director · since 2022
Kurtulus Varoglu
Non-Executive Independent Director · since 2023
Buelent Yetis
Non-Executive Independent Director · since 2020
Headquarters & legal address
GEBZE ORGANİZE SANAYİ BÖLGESİ 700 SOKAK NO:711
KOCAELİ 41480
TR
KOCAELİ 41480
TR
Valuation
Title TRY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||